You are here
Enabling Technologies
Platform technologies for therapeutic and diagnostic applications are available for co-development and/or licensing.
mutREAD is a novel DNA sequencing method that measures the presence of mutational signatures in all types of clinical and biological samples.
Read morePatented technology that allows manipulation of the disulfide bond configuration of the hinge/CH1 regions to control the activity of mAbs directed against a range of immune receptors.
Read morePlease see https://medphys.royalsurrey.nhs.uk/omidb for detailed information.
Read more